Cellular Biomedicine Group Short Interest Ratio and Short Volume

Short interest is the volume of Cellular Biomedicine Group shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 266,600 shares of CBMG short. 2.33% of Cellular Biomedicine Group's shares are currently sold short. View details.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Cellular Biomedicine Group currently has a short interest ratio of 6.0.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.33% of Cellular Biomedicine Group's floating shares are currently sold short.

Cellular Biomedicine Group saw a decline in short interest in the month of December. As of December 31st, there was short interest totaling 266,600 shares, a decline of 23.1% from the previous total of 346,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Cellular Biomedicine Group currently has issued a total of 19,478,000 shares. Some of Cellular Biomedicine Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cellular Biomedicine Group currently has a public float of 11,460,000 shares.

2.33% of Cellular Biomedicine Group's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Cellular Biomedicine Group: Krystal Biotech, Inc. (10.00%), Cellectis S.A. (2.09%), Coherus BioSciences, Inc. (21.59%), Alector, Inc. (14.84%), Adverum Biotechnologies, Inc. (0.00%), Mesoblast Limited (0.00%), Sutro Biopharma, Inc. (0.00%), Gritstone Oncology, Inc. (7.41%), TCR2 Therapeutics Inc. (10.12%), and Cortexyme, Inc. (17.62%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

Short selling CBMG is an investing strategy that aims to generate trading profit from Cellular Biomedicine Group as its price is falling. Cellular Biomedicine Group's stock is trading up $0.24 today. To short Cellular Biomedicine Group stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Cellular Biomedicine Group will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cellular Biomedicine Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CBMG, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBMG, twice per month. The most recent reporting period available is December, 31 2020.